Sarcoma

The goal of cancer immunotherapy is to improve the body’s natural ability to find and destroy cancer cells. Successful immunotherapeutic approaches stimulate the natural defenses of the immune system and provide new ways to attack cancer. This is possible with comprehensive interventions that include cell therapy / immuno-pharmacological therapy in combination with
nutritional, endocrine measures and supplements.

T-cell Modulators are peptide chains composed of tens of amino acids that appear to store all the experience of the immune system. The great intellectual leap to understand is that T-cell

Modulators do not transfer antibodies nor create them directly, but its function is to educate, and teach the immune cells to recognize specific antigens that could happen to them unnoticed i.e. Prostate malignant cells.

T-cell Modulators do not cure anything but work to make a “smarter” immune system so that it is the body itself eliminating disease. They are therefore vital in developing the strategies of the immune system against cancer.

T-cell Modulators contains several immunoactivity components that have been shown to act synergistically in raising Dendritic and NK function and also effective as adjuvant therapy in soft tissue sarcoma, elevating dendritic and NK function as much as 250%.

Hyperthermia involves the use of heat to directly treat a tumor or increase the vulnerability of cancer cells to other forms of treatment, such as immunotherapy, B17, vitamin C, chemotherapy or radiotherapy.

Concerning clinical trials, hyperthermia has already shown antitumor activity and has a potential role in the treatment of soft tissue sarcomas.

Non-ablative or mild hyperthermia (HT) has been shown in preclinical and clinical studies as a localized sensitizer that enhances the tumoricidal effects of immunotherapy, radiation or chemotherapy. A minimally invasive interventional technique, (Hyperthermia) has been suggested to improve the efficacy of chemotherapy for soft tissues sarcomas.

Mistletoe helps fight tumor-induced immune suppression. Natural killer cells (NK) are a type of white blood cell that looks for and destroys Prostate cancer cells. Research has shown that NK cells can spontaneously recognize and kill a variety of cancer cells.

Mistletoe has been called a biological response modifier due to its ability to improve various aspects of immune function. Studies show that it activates natural killer cells, T cells, macrophages and monocytes.

A special proprietary form of liposomal mistletoe created with nanotechnology has been created for use in our Prostate cancer treatment approach.

Glutathione is the most important antioxidant produced by your body and a master detoxifier of every cell in your body. It prevents cellular damage caused by free radicals and peroxides. Glutathione metabolism can play both protective and pathogenic roles. It is crucial in the removal and detoxification of carcinogens, and alterations in this pathway can have a profound effect on cell survival. However, by conferring resistance to several chemotherapeutic drugs, elevated levels of glutathione in tumor cells can protect such cells.

A typical diet, characterized by dependence on animal products, refined carbohydrates and

unhealthy fats such as processed vegetable oils, can promote an inflammatory environment in the body. A pro-inflammatory diet has been associated with an increased risk of soft tissue sarcoma and an increased risk of death from Prostate cancer.

We custom-make a diet targeted to enhance the immune system’s ability to heal and provide our patients with the right nutrition for their current and long-term needs

Patients with higher vitamin D levels were significantly less likely to die from the disease. In another study, short-term supplementation with high-dose vitamin D for three to eight weeks lowered PSA levels (Wagner 2013).

Hormone therapy can weaken the bones of prostate cancer patients, but supplemental vitamin D may help prevent fractures in these patients (Ottanelli 2015; Dueregger 2014)

Healthy prostate cells accumulate zinc to accomplish their normal cellular functions. In contrast, prostate cancer cells have depleted zinc stores, which makes them less susceptible to cell death.

Melatonin, a hormone best known for its role in regulating sleep, is also emerging as a promising anti-cancer agent. Evidence to date has shown that melatonin can interfere with cancer initiation, progression, and metastasis.

These fatty acids have many health benefits and may even slow the growth of soft tissue sarcoma. In laboratory and animal studies, omega-3 fatty acids were found to inhibit inflammation, interfere with blood vessel growth in tumors, and cause cancer cells to die.